← FDA Drug Approvals (Drugs@FDA)

LIRAGLUTIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN INSTITUTIONAL · Approved 2026-06-15

Drug application

FDA Application #

ANDA213155

Application type

Abbreviated New Drug Application (Generic)

Brand name

LIRAGLUTIDE

Generic name

Liraglutide

Active ingredients

LIRAGLUTIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

MYLAN INSTITUTIONAL

First approval

2026-06-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown